I don’t believe there is any connection to Todos or lympro, and would probably be a competitor, but it’s certainly a strong call for an effective Alzheimer’s blood test and might invigorate the industry. I wonder how much has to be done to get lympro 2.0 moving

https://www.scientificamerican.com/article/a-...lzheimers/